Trial Profile
A Randomized Phase II Study of PEP02 or Irinotecan in Combination With Leucovorin and 5-Fluorouracil in Second Line Therapy of Metastatic Colorectal Cancer
Status:
Suspended
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Bevacizumab; Fluorouracil; Folinic acid
- Indications Colorectal cancer
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms PEPCOL
- 14 Nov 2013 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
- 21 Jun 2011 New trial record